Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
News
2014
Working Paper 6 – The Role of Health Technology Assessment in Medicine Pricing and Reimbursement
Policy Brief 4 – Competition Policy
Policy Brief 1 – External Reference Pricing
Working Paper 2 – The Role of Health Insurance in the Cost-Effective Use of Medicines
Working Paper 5 – Sales Taxes on Medicines
Working Paper 3: The Regulation of Mark-ups in the Pharmaceutical Supply Chain
Understanding and Responding To Medicines Promotion
2013
The Status Quo Wins Again: Selected R&D Demonstration Projects Disappoint, Offer Little Progress (2013)
EU Regulation on Clinical Trials: Further enhance clinical data transparency
Transparency of Clinical Trial Data on Medicines in the EU
Transparency in the Public Interest: How the EMA Policy on Publication and Access to Cinical-trial Data Could Help Save Lives
Trade, TRIPS+, & Access to Medicines
EU-Thailand Free Trade Agreement: Not at the expense of access to medicines
HAI Europe Calls on EFPIA and PhRMA to Truly Commit to Clinical Trial Data Transparency
LAC-Global Alliance Statement on Trans-Pacific Partnership and Access to Affordable Medicines
NGOs Condemn the EU Press Release on TRIPS Extension for Least Developed Countries
Long-awaited Steps Towards Affordable Access and Needs-driven Research and Development
Comprendre la promotion pharmaceutique et y répondre: Un manuel pratique
EU-India free trade deal puts millions of lives at risk
La Alianza LAC-Global reconoce el paso dado por el Medicines Patent Pool
2012 Annual Report
2012 Financial Statements
2012